These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6142350)

  • 1. Evidence that thyroid-stimulating antibody is produced in the thyroid gland.
    Kendall-Taylor P; Knox AJ; Steel NR; Atkinson S
    Lancet; 1984 Mar; 1(8378):654-6. PubMed ID: 6142350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid stimulating antibodies (TSAb) in patients with Graves' disease undergoing antithyroid drug treatment: indicators of activity of disease.
    Karlsson FA; Dahlberg PA
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):579-85. PubMed ID: 6895352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves' disease.
    Steel NR; Taylor JJ; Young ET; Farndon JR; Holcombe M; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1987 Jan; 26(1):97-106. PubMed ID: 3802553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.
    Hörmann R; Saller B; Müller R; Mann K
    Klin Wochenschr; 1985 Dec; 63(24):1247-52. PubMed ID: 2868149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?
    Madec AM; Laurent MC; Lorcy Y; Le Guerrier AM; Rostagnat-Stefanutti A; Orgiazzi J; Allannic H
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):247-55. PubMed ID: 6148163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid stimulating antibody: an index of thyroid stimulation in Graves' disease?
    Baldet L; Madec AM; Papachristou C; Stefanutti A; Orgiazzi J; Jaffiol C
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):7-12. PubMed ID: 2889309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
    Bliddal H; Bech K; Siersbaek-Nielsen K; Friis T
    J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid-stimulating antibodies in patients with long-term remission of Graves' hyperthyroidism.
    Hörmann R; Hobelsberger A; Saller B; Mann K
    Klin Wochenschr; 1986 Oct; 64(21):1097-100. PubMed ID: 2879958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease.
    Edan G; Massart C; Hody B; Poirier JY; Lé Reun M; Hespel JP; Leclech G; Simon M
    BMJ; 1989 Feb; 298(6670):359-61. PubMed ID: 2564286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid-stimulating antibody (TSAb) of Graves' disease.
    Zakarija M; McKenzie JM
    Life Sci; 1983 Jan 3-10; 32(1-2):31-44. PubMed ID: 6131365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of radioiodine on stimulatory activity of Graves' immunoglobulins.
    Atkinson S; McGregor AM; Kendall-Taylor P; Peterson MM; Smith BR
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):537-43. PubMed ID: 6125279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
    Takasu N; Yamashiro K; Ochi Y; Sato Y; Nagata A; Komiya I; Yoshimura H
    Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.